TITLE:
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis

CONDITION:
Postmenopausal Osteoporosis

INTERVENTION:
AMG 162

SUMMARY:

      This study will determine whether treatment with AMG 162 can prevent lumbar spine bone loss
      in both early and late postmenopausal women with osteopenia, and to further test the safety
      and tolerability of AMG 162 in this population.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: N/A to 90 Years
Criteria:

        Eligibility Criteria

        - Postmenopausal women with Osteopenia (lumbar spine bone mineral density T-score between
        1.0 and -2.5)
      
